BioSpace News Archive

Genmab A/S (Nasdaq: GMAB) today announced its intent to submit a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for subcutaneous epcoritamab (DuoBody®-CD3xCD20), an investigational bispecific antibody, for the treatment of patients with relapsed/refractory large B-cell lymphoma (LBCL), in the second half of 2022.

The latest market analysis report published by Reports and Data, titled ‘Global Orthopedic Bioactive Glass Market – Forecast to 2028,’ thoroughly examines the Orthopedic Bioactive Glass industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Potassium Guaiacolsulfonate Market – Forecast to 2027,’ thoroughly examines the Potassium Guaiacolsulfonate industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Cordyceps Supplements Market – Forecast to 2027,’ thoroughly examines the Cordyceps Supplements industry to provide essential data & information for the targeted readers.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), today confirmed that it has received an unsolicited, non-binding proposal from Kennedy Lewis Investment Management LLC to acquire all of the outstanding shares of the Company for $5.00 per share in cash.

Quest Analytics, the leader in provider network management solutions and services, today introduced three new features for Quest Enterprise Services (QES) designed to improve their client’s ability to address the No Surprises Act (NSA) and the evolving provider network regulations.

After a year of sustained advocacy from the ophthalmology community, Aetna announced this week that it will no longer require pre-approval for cataract surgeries starting July 1, 2022, except for people enrolled in Medicare Advantage in Florida and Georgia.

The International Centers for Precision Oncology (ICPO) Foundation is pleased to announce that its first Maurits W. Geerlings Next Generation Award presentation for Outstanding Research and Contributions to Actinium-225 Radiopharmaceuticals took place on Friday, June 24 during the 6th TWC in Wiesbaden, Germany (Congress President: Professor Dr. Richard P. Baum).

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) today announced that effective immediately, Gavriel Lambert will be serving on its Board of Advisors

The “Healthcare and Medical System Integrators Market Growth (Status and Outlook)” Study has been added to Data Bridge Market Research’s repository.